TCL Archive Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months May 31, 2013
TCL Archive Mendelsohn Defends ImClone’s Actions And His Role In Development of C225 October 18, 2002
TCL Archive NCAB Votes Down Effort to Delay CCOP RFA, Directs Subcommittee To Look Again A Program Components February 12, 1982
TCL Archive Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now December 2, 1983
TCL Archive In Brief: Lasagna Committee Report Finalized; Robinson Replaces Schmidt On MSK Boards July 13, 1990
